Login / Signup

Dupilumab therapy following JAK inhibitor withdrawal in moderate-severe atopic dermatitis.

Lisa KielyCathal O'ConnorMichelle Murphy
Published in: Dermatologic therapy (2022)
Keyphrases
  • atopic dermatitis
  • high intensity
  • early onset
  • bone marrow
  • mesenchymal stem cells
  • replacement therapy